Investment House LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-969
Closed -$431K – 239
2025
Q2
$431K Sell
969
-75
-7% -$34.6K 0.02% 184
2025
Q1
$506K Buy
1,044
+99
+10% +$46.1K 0.03% 176
2024
Q4
$381K Buy
945
+85
+10% +$39.4K 0.02% 175
2024
Q3
$400K Buy
860
+35
+4% +$16.8K 0.02% 178
2024
Q2
$387K Buy
825
+145
+21% +$62.9K 0.02% 170
2024
Q1
$284K Buy
680
+100
+17% +$42.3K 0.02% 192
2023
Q4
$236K Hold
580
– – 0.02% 183
2023
Q3
$202K Hold
580
– – 0.02% 177
2023
Q2
$204K Buy
+580
New +$195K 0.02% 183
2021
Q4
– Sell
-10,795
Closed -$1.96M – 193
2021
Q3
$1.96M Sell
10,795
-4,986
-32% -$973K 0.14% 83
2021
Q2
$3.18M Buy
15,781
+145
+0.9% +$30.3K 0.22% 77
2021
Q1
$3.36M Buy
15,636
+640
+4% +$141K 0.26% 75
2020
Q4
$3.54M Buy
14,996
+1,910
+15% +$438K 0.25% 75
2020
Q3
$3.56M Buy
13,086
+1,230
+10% +$339K 0.28% 70
2020
Q2
$3.44M Buy
11,856
+5,480
+86% +$1.49M 0.3% 71
2020
Q1
$1.52M Buy
+6,376
New +$1.46M 0.17% 87

Other funds holding VRTX

Investment House LLC's VRTX Position: Q3 2025 in Review

Investment House LLC sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 969 shares — an estimated $431K sold.

Investment House LLC first reported a position in VRTX in Q1 2020 and held it in 16 quarters. The position peaked at $3.56M in Q3 2020. 1,523 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Investment House LLC reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Investment House LLC sold 969 Vertex Pharmaceuticals shares in Q3 2025, an estimated $431K.
  • Investment House LLC first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 16 quarters.
  • Investment House LLC's Vertex Pharmaceuticals position peaked at $3.56M in Q3 2020.
  • 1,523 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Investment House LLC's 13F filing for Q3 2025, filed 31 Oct 2025.